KLRA KAILERA THERAPEUTICS INC revenue, earnings and financials
For the quarter ended June 30, 2026, KAILERA THERAPEUTICS INC reported revenue of n/a, net income of −$111M and diluted EPS of −$1.09.
KLRA quarterly revenue and earnings
- Quarter ended Jun 30, 2026: revenue n/a, net income −$111M, EPS −$1.09
- Quarter ended Mar 31, 2026: revenue n/a, net income −$78.9M, EPS −$3650.00
- Quarter ended Jun 30, 2025: revenue n/a, net income −$28.9M, EPS −$28947.00
- Quarter ended Mar 31, 2025: revenue n/a, net income −$18.0M, EPS −$17983.00
KLRA balance sheet
- Jun 30, 2026: cash $130M, total assets $1.21B, total liabilities $93.0M, shareholders' equity $1.12B
- Mar 31, 2026: cash $112M, total assets $625M, total liabilities $64.5M, shareholders' equity −$432M
- Dec 31, 2025: cash $160M, total assets $692M, total liabilities $56.4M, shareholders' equity −$356M